QURE
insider transactionsuniQure N.V. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-239.7K
0 buy · 239.7K sell
Net value · 365d
-$4.8M
$0 in · $4.8M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
30
0 buy · 239.7K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Chief Legal Officer
$144.9K
5.2K sh · $27.67
Own -4%
-
Exercise·M
Director · 10b5-1
$0
10.0K sh
Own New
-
Sell·S
Director · 10b5-1
$278.5K
10.0K sh · $27.85
Own -19%
-
Exercise·M
Director · 10b5-1
$84.9K
10.0K sh · $8.49
Own +23%
-
Sell·S
Director
$53.9K
2.0K sh · $27.06
Own -4%
-
Sell·S
Director
$53.9K
2.0K sh · $27.06
Own -5%
-
Sell·S
Chief Customer & Strat Officer
$431.2K
15.9K sh · $27.06
Own -13%
-
Sell·S
Director
$53.9K
2.0K sh · $27.06
Own -5%
-
Sell·S
Director
$53.9K
2.0K sh · $27.06
Own -7%
-
Sell·S
Director
$53.9K
2.0K sh · $27.06
Own -6%
-
Sell·S
Director · 10b5-1
$73.8K
2.7K sh · $27.06
Own -8%
-
Sell·S
Director
$53.9K
2.0K sh · $27.06
Own -4%
-
Grant·A
Director
$0
14.0K sh
Own New
-
Grant·A
Director
$0
7.5K sh
Own +20%
-
Grant·A
Director
$0
14.0K sh
Own New
-
Grant·A
Director
$0
7.5K sh
Own +25%
-
Grant·A
Director
$0
14.0K sh
Own New
-
Grant·A
Director
$0
7.5K sh
Own +22%
-
Grant·A
Director
$0
14.0K sh
Own New
-
Grant·A
Director
$0
7.5K sh
Own +37%
-
Grant·A
Director
$0
14.0K sh
Own New
-
Grant·A
Director
$0
7.5K sh
Own +27%
-
Grant·A
Director · 10b5-1
$0
14.0K sh
Own New
-
Exercise·M
Director · 10b5-1
$0
2.6K sh
Own New
-
Grant·A
Director · 10b5-1
$0
7.5K sh
Own +28%
-
Sell·S
Director · 10b5-1
$46.4K
1.8K sh · $26.05
Own -6%
-
Sell·S
Director · 10b5-1
$81.4K
3.1K sh · $26.03
Own -10%
-
Sell·S
Director · 10b5-1
$69.0K
2.6K sh · $26.07
Own -8%
-
Exercise·M
Director · 10b5-1
$42.4K
2.6K sh · $16.04
Own +8%
-
Grant·A
Director
$0
14.0K sh
Own New
-
Grant·A
Director
$0
7.5K sh
Own +20%
-
Exercise·M
Director · 10b5-1
$0
2.6K sh
Own New
-
Sell·S
Director · 10b5-1
$79.4K
2.6K sh · $30.01
Own -11%
-
Exercise·M
Director · 10b5-1
$42.4K
2.6K sh · $16.04
Own +13%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
25.0K sh
Own +70%
-
Sell·S
Chief Medical Officer · 10b5-1
$500.0K
20.0K sh · $25.00
Own -11%
-
Sell·S
Chief Medical Officer · 10b5-1
$627.5K
25.0K sh · $25.10
Own -12%
-
Exercise·M
Chief Medical Officer · 10b5-1
$139.8K
25.0K sh · $5.59
Own +13%
-
Grant·A
Director
$0
44.5K sh
Own New
-
Grant·A
Chief Legal Officer
$0
57.2K sh
Own New
-
Sell·S
Chief Legal Officer
$30.9K
3.4K sh · $9.06
Own -2%
-
Grant·A
Chief Legal Officer
$0
35.4K sh
Own +33%
-
Grant·A
CEO, Managing Director
$0
113.8K sh
Own New
-
Sell·S
CEO, Managing Director
$132.1K
14.6K sh · $9.06
Own -2%
-
Grant·A
CEO, Managing Director
$0
70.6K sh
Own +12%
-
Grant·A
Christian Klemt KEY
Chief Financial Officer
$0
63.9K sh
Own New
-
Sell·S
Christian Klemt KEY
Chief Financial Officer
$108.7K
12.0K sh · $9.06
Own -5%
-
Grant·A
Christian Klemt KEY
Chief Financial Officer
$0
39.6K sh
Own +20%
-
Grant·A
Chief Medical Officer
$0
67.2K sh
Own New
-
Sell·S
Chief Medical Officer
$7.3K
808 sh · $9.06
Own -0%
-
Grant·A
Chief Medical Officer
$0
41.7K sh
Own +28%
-
Grant·A
Chief Customer & Strat Officer
$0
31.9K sh
Own New
-
Grant·A
Chief Customer & Strat Officer
$0
19.8K sh
Own +19%
-
Sell·S
Chief Legal Officer
$85.4K
8.6K sh · $9.95
Own -7%
-
Sell·S
CEO, Managing Director
$342.6K
34.4K sh · $9.95
Own -5%
-
Sell·S
Christian Klemt KEY
Chief Financial Officer
$124.7K
12.5K sh · $9.95
Own -6%
-
Sell·S
Chief Medical Officer
$16.5K
1.7K sh · $9.95
Own -1%
-
Sell·S
CEO, Managing Director
$295.3K
12.4K sh · $23.86
Own -2%
-
Sell·S
Christian Klemt KEY
Chief Financial Officer
$148.3K
6.2K sh · $23.86
Own -3%
-
Exercise·M
Director · 10b5-1
$0
17.8K sh
Own New
-
Sell·S
Director · 10b5-1
$195.8K
7.8K sh · $25.09
Own -19%
-
Sell·S
Director · 10b5-1
$12.5K
500 sh · $25.03
Own -1%
-
Sell·S
Director · 10b5-1
$422.2K
17.3K sh · $24.39
Own -30%
-
Exercise·M
Director · 10b5-1
$250.8K
17.8K sh · $14.08
Own +44%
-
Exercise·M
Director · 10b5-1
$0
6.4K sh
Own New
-
Sell·S
Director · 10b5-1
$174.3K
6.4K sh · $27.28
Own -24%
-
Exercise·M
Director · 10b5-1
$123.9K
6.4K sh · $19.39
Own +31%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Jeannette Potts | Sell S | 5.2K | $144.9K |
| Jun 15, 2026 | Madhavan Balachandran 10b5-1 | Exercise M | 10.0K | $0 |
| Jun 15, 2026 | Madhavan Balachandran 10b5-1 | Sell S | 10.0K | $278.5K |
| Jun 15, 2026 | Madhavan Balachandran 10b5-1 | Exercise M | 10.0K | $84.9K |
| Jun 11, 2026 | Jeremy P. Springhorn | Sell S | 2.0K | $53.9K |
| Jun 11, 2026 | Leonard E Post | Sell S | 2.0K | $53.9K |
| Jun 11, 2026 | Kylie O'Keefe | Sell S | 15.9K | $431.2K |
| Jun 11, 2026 | David D. Meek | Sell S | 2.0K | $53.9K |
| Jun 11, 2026 | Jack Kaye | Sell S | 2.0K | $53.9K |
| Jun 11, 2026 | Rachelle Suzanne Jacques | Sell S | 2.0K | $53.9K |
| Jun 11, 2026 | Robert Gut 10b5-1 | Sell S | 2.7K | $73.8K |
| Jun 11, 2026 | Madhavan Balachandran | Sell S | 2.0K | $53.9K |
| Jun 10, 2026 | Jeremy P. Springhorn | Grant A | 14.0K | $0 |
| Jun 10, 2026 | Jeremy P. Springhorn | Grant A | 7.5K | $0 |
| Jun 10, 2026 | Leonard E Post | Grant A | 14.0K | $0 |
| Jun 10, 2026 | Leonard E Post | Grant A | 7.5K | $0 |
| Jun 10, 2026 | David D. Meek | Grant A | 14.0K | $0 |
| Jun 10, 2026 | David D. Meek | Grant A | 7.5K | $0 |
| Jun 10, 2026 | Jack Kaye | Grant A | 14.0K | $0 |
| Jun 10, 2026 | Jack Kaye | Grant A | 7.5K | $0 |
| Jun 10, 2026 | Rachelle Suzanne Jacques | Grant A | 14.0K | $0 |
| Jun 10, 2026 | Rachelle Suzanne Jacques | Grant A | 7.5K | $0 |
| Jun 10, 2026 | Robert Gut 10b5-1 | Grant A | 14.0K | $0 |
| Jun 10, 2026 | Robert Gut 10b5-1 | Exercise M | 2.6K | $0 |
| Jun 10, 2026 | Robert Gut 10b5-1 | Grant A | 7.5K | $0 |
| Jun 10, 2026 | Robert Gut 10b5-1 | Sell S | 1.8K | $46.4K |
| Jun 10, 2026 | Robert Gut 10b5-1 | Sell S | 3.1K | $81.4K |
| Jun 10, 2026 | Robert Gut 10b5-1 | Sell S | 2.6K | $69.0K |
| Jun 10, 2026 | Robert Gut 10b5-1 | Exercise M | 2.6K | $42.4K |
| Jun 10, 2026 | Madhavan Balachandran | Grant A | 14.0K | $0 |
| Jun 10, 2026 | Madhavan Balachandran | Grant A | 7.5K | $0 |
| Jun 3, 2026 | Jack Kaye 10b5-1 | Exercise M | 2.6K | $0 |
| Jun 3, 2026 | Jack Kaye 10b5-1 | Sell S | 2.6K | $79.4K |
| Jun 3, 2026 | Jack Kaye 10b5-1 | Exercise M | 2.6K | $42.4K |
| May 8, 2026 | Walid Abi-Saab 10b5-1 | Exercise M | 25.0K | $0 |
| May 8, 2026 | Walid Abi-Saab 10b5-1 | Sell S | 20.0K | $500.0K |
| May 8, 2026 | Walid Abi-Saab 10b5-1 | Sell S | 25.0K | $627.5K |
| May 8, 2026 | Walid Abi-Saab 10b5-1 | Exercise M | 25.0K | $139.8K |
| Apr 1, 2026 | Madhavan Balachandran | Grant A | 44.5K | $0 |
| Mar 4, 2026 | Jeannette Potts | Grant A | 57.2K | $0 |
| Mar 4, 2026 | Jeannette Potts | Sell S | 3.4K | $30.9K |
| Mar 4, 2026 | Jeannette Potts | Grant A | 35.4K | $0 |
| Mar 4, 2026 | Matthew C Kapusta KEY | Grant A | 113.8K | $0 |
| Mar 4, 2026 | Matthew C Kapusta KEY | Sell S | 14.6K | $132.1K |
| Mar 4, 2026 | Matthew C Kapusta KEY | Grant A | 70.6K | $0 |
| Mar 4, 2026 | Christian Klemt KEY | Grant A | 63.9K | $0 |
| Mar 4, 2026 | Christian Klemt KEY | Sell S | 12.0K | $108.7K |
| Mar 4, 2026 | Christian Klemt KEY | Grant A | 39.6K | $0 |
| Mar 4, 2026 | Walid Abi-Saab | Grant A | 67.2K | $0 |
| Mar 4, 2026 | Walid Abi-Saab | Sell S | 808 | $7.3K |
| Mar 4, 2026 | Walid Abi-Saab | Grant A | 41.7K | $0 |
| Mar 4, 2026 | Kylie O'Keefe | Grant A | 31.9K | $0 |
| Mar 4, 2026 | Kylie O'Keefe | Grant A | 19.8K | $0 |
| Mar 2, 2026 | Jeannette Potts | Sell S | 8.6K | $85.4K |
| Mar 2, 2026 | Matthew C Kapusta KEY | Sell S | 34.4K | $342.6K |
| Mar 2, 2026 | Christian Klemt KEY | Sell S | 12.5K | $124.7K |
| Mar 2, 2026 | Walid Abi-Saab | Sell S | 1.7K | $16.5K |
| Feb 25, 2026 | Matthew C Kapusta KEY | Sell S | 12.4K | $295.3K |
| Feb 25, 2026 | Christian Klemt KEY | Sell S | 6.2K | $148.3K |
| Jan 12, 2026 | Robert Gut 10b5-1 | Exercise M | 17.8K | $0 |
| Jan 12, 2026 | Robert Gut 10b5-1 | Sell S | 7.8K | $195.8K |
| Jan 12, 2026 | Robert Gut 10b5-1 | Sell S | 500 | $12.5K |
| Jan 12, 2026 | Robert Gut 10b5-1 | Sell S | 17.3K | $422.2K |
| Jan 12, 2026 | Robert Gut 10b5-1 | Exercise M | 17.8K | $250.8K |
| Jan 9, 2026 | Jack Kaye 10b5-1 | Exercise M | 6.4K | $0 |
| Jan 9, 2026 | Jack Kaye 10b5-1 | Sell S | 6.4K | $174.3K |
| Jan 9, 2026 | Jack Kaye 10b5-1 | Exercise M | 6.4K | $123.9K |
About QURE insider trading
This page tracks insider transactions for uniQure N.V. (QURE) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.